| Application no. and date | 03767663.2 (espacenet) (Federated) (European Patent Register), 20031126 | | Patent/reg. no. and date | DK/EP 1567139, 20080702 | | Publication date | 20050831 | | Priority no. and date | EP 02026505, 20021127 | | EP pub. no. and date |
EP 1567139 20050831 | | Effective date | | | Applicant/owner | AstraZeneca AB,
SE 151 85 Södertälje, SE | | Applicant ref. no. | P44597DK01 | | Inventor | BEUME, Rolf, Bohlstrasse 13
78465 Konstanz, DE,
MARX, Degenhard, Obere Reute 15
78345 Moos, DE,
WEIMAR, Christian, Helene und Maria Schiess-Strasse 29
78467 Konstanz, DE,
BUNDSCHUH, Daniela, Im Rank 5
8272 Ermatingen, CH,
KOLASSA, Norbert, Christoph-Daniel-Schenck-Str. 27
78464 Konstanz, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/167 (2006.01) , A61K 31/44 (2006.01) , A61P 11/00 (2006.01) | | Title | Hidtil ukendt synergistisk kombination der omfatter roflumilast og formoterol | | Int. application no. | EP2003013275 | | Int. publication no. | WO2004047829 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
